Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

December 1, 2024; Volume 65,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Fendler, Wolfgang Peter

    1. Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
      You have access
      Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
      Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke, Werner Schmid, Frederik Giesel, Lena Häberle, Irene Esposito, Wilfried Budach, Johannes Grueneisen, Christiane Matuschek, Bernd Kowall, Andreas Stang, Gerald Antoch and Christian Buchbender
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1855-1861; DOI: https://doi.org/10.2967/jnumed.124.268065
  2. Flowers, William L.

    1. Open Access
      Precision Oncology in Melanoma: Changing Practices
      Sean C. Dougherty, William L. Flowers and Elizabeth M. Gaughan
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1838-1845; DOI: https://doi.org/10.2967/jnumed.124.267781
  3. Flux, Glenn

    1. You have access
      The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice
      Manuel Bardiès, Glenn Flux and Katarina Sjögreen Gleisner
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1846-1847; DOI: https://doi.org/10.2967/jnumed.124.267742
  4. Fodor, Andrei

    1. You have access
      One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study
      Andrei Fodor, Cristiano Pini, Gaia Ninatti, Nadia Di Muzio and Arturo Chiti
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1984; DOI: https://doi.org/10.2967/jnumed.124.268395
  5. Forde, Patrick M.

    1. [<sup>18</sup>F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
      You have access
      [18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
      Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk and Hee-Don Chae
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1869-1875; DOI: https://doi.org/10.2967/jnumed.124.268253
  6. Fu, Haitian

    1. Value of [<sup>68</sup>Ga]Ga-NYM046 PET/CT, in Comparison with <sup>18</sup>F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma
      Open Access
      Value of [68Ga]Ga-NYM046 PET/CT, in Comparison with 18F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma
      Kequan Lou, Jialiang Wang, Huihui He, Yanjuan Wang, Yuanyuan Mi, Wenjin Li, Liping Chen, Yu Zhang, Yong Mao, Jianguo Lin, Haitian Fu and Chunjing Yu
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1884-1890; DOI: https://doi.org/10.2967/jnumed.124.267527
  7. Gable, Alexander

    1. Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
      You have access
      Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
      Adriana Amerein, Christoph Maurer, Malte Kircher, Alexander Gäble, Anne Krebold, Andreas Rinscheid, Oliver Viering, Christian H. Pfob, Ralph A. Bundschuh, Lars Behrens, Arthur JAT Braat, Ansgar Berlis and Constantin Lapa
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1911-1916; DOI: https://doi.org/10.2967/jnumed.124.268217
  8. Gaughan, Elizabeth M.

    1. Open Access
      Precision Oncology in Melanoma: Changing Practices
      Sean C. Dougherty, William L. Flowers and Elizabeth M. Gaughan
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1838-1845; DOI: https://doi.org/10.2967/jnumed.124.267781
  9. Gelardi, Fabrizia

    1. Immuno-PET/CT Imaging of Trop2 with [<sup>18</sup>F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
      You have access
      Immuno-PET/CT Imaging of Trop2 with [18F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
      Wei Huang, Min Cao, Yanfei Wu, You Zhang, Shuxian An, Xinbing Pan, Xinyuan Zhou, Hongda Shao, Yihui Guan, Gang Huang, Fabrizia Gelardi, Arturo Chiti, Fang Xie, Jianjun Liu and Weijun Wei
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1904-1910; DOI: https://doi.org/10.2967/jnumed.124.268751
  10. Giesel, Frederik

    1. Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
      You have access
      Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
      Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke, Werner Schmid, Frederik Giesel, Lena Häberle, Irene Esposito, Wilfried Budach, Johannes Grueneisen, Christiane Matuschek, Bernd Kowall, Andreas Stang, Gerald Antoch and Christian Buchbender
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1855-1861; DOI: https://doi.org/10.2967/jnumed.124.268065
    2. Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
      You have access
      Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
      Andreas Helisch, Clemens Kratochwil, Christian Kleist, Susanne Krämer, Juan Jose Rosales Castillo, Katharina Dendl, Hendrik Rathke, Isabelle von Goetze, Mathias Schreckenberger, Dirk Jäger, Thomas Lindner, Walter Mier, Frederik Giesel, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine December 1, 2024, 65 (12) 1917-1922; DOI: https://doi.org/10.2967/jnumed.124.268386
« Previous (Pages : 4 5 6 7 8 9 10 11 12 13 ... 28) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (12)
Journal of Nuclear Medicine
Vol. 65, Issue 12
December 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
  • Immuno-PET/CT Imaging of Trop2 with [18F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire